Phạm, T. L. et al. (2024) “RESULT OF PEMBROLIZUMAB PLUS CHEMOTHERAPY IN THE FIRST-LINE THERAPY FOR DISTANT METASTATIC NON-SMALL-CELL LUNG CANCER WITH PD-L1 ≥1%, EGFR(-), ALK(-) AND ROS1(-)”, Journal of 175 Practical Medicine and Pharmacy, (37), p. 13. doi: 10.59354/ydth175.2024.240.